1
|
Chen ZC, Liu RX, Xie YJ, Hu Q, Huang FP, Liu YC, Liang H. Marbofloxacin combined with heavy rare-earth ions makes better candidates for veterinary drugs: crystal structure and bio-activity studies. Dalton Trans 2024; 53:4204-4213. [PMID: 38323916 DOI: 10.1039/d3dt03343k] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2024]
Abstract
Marbofloxacin (MB) is a newly developed fluoroquinolone antibiotic used especially as a veterinary drug. It may be regarded as the improved version of enrofloxacin owing to its antibacterial activity, enhanced bioavailability, and pharmacokinetic-pharmacodynamic (PK-PD) properties. In this study, nine heavy rare-earth ions (Y, Gd, Tb, Dy, Ho, Er, Tm, Yb, and Lu) were selected in light of their potential antibacterial activity and satisfactory biosafety to afford the corresponding rare-earth metal complexes of MB: the MB-Ln series. Their chemical structures and coordination patterns were characterized using IR spectroscopy, HRMS, TGA, and X-ray single-crystal diffraction analysis. Our results confirmed that all the MB-Ln complexes yielded the coincident coordination modes with four MB ligands coordinating to the Ln(III) center. In vitro antibacterial screening on five typical bacteria strains revealed that the MB-Ln complexes exhibited antibacterial activities comparable with MB, as indicated by the MIC/MBC values, in which Escherichia coli and Salmonella typhi were the most sensitive ones to MB-Ln. Furthermore, the MB-Ln complexes were found to be much less toxic in vivo than MB, as suggested by the evaluated LD50 (50% lethal dose) values. All the MB-Ln series complexes fell in the LD50 range of 5000-15 000 mg kg-1, while the LD50 value of MB was only 1294 mg kg-1. Furthermore, MB-Lu, as the selected representative of MB-Ln, could effectively inhibit the activity of DNA gyrase, the same as MB, suggesting the primary antibacterial mechanism of the MB-Ln series. The results demonstrated the good prospects and potential of metal-based veterinary drugs with better drug performance.
Collapse
Affiliation(s)
- Zhi-Chuan Chen
- School of Chemistry and Pharmaceutical Sciences, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, Guangxi Normal University, Guilin, 541004, China.
| | - Rui-Xue Liu
- School of Chemistry and Pharmaceutical Sciences, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, Guangxi Normal University, Guilin, 541004, China.
- Department of Chemistry, Southern University of Science and Technology, Shenzhen, 518055, China
| | - Yan-Jie Xie
- School of Chemistry and Pharmaceutical Sciences, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, Guangxi Normal University, Guilin, 541004, China.
| | - Qin Hu
- School of Chemistry and Pharmaceutical Sciences, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, Guangxi Normal University, Guilin, 541004, China.
| | - Fu-Ping Huang
- School of Chemistry and Pharmaceutical Sciences, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, Guangxi Normal University, Guilin, 541004, China.
| | - Yan-Cheng Liu
- School of Chemistry and Pharmaceutical Sciences, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, Guangxi Normal University, Guilin, 541004, China.
| | - Hong Liang
- School of Chemistry and Pharmaceutical Sciences, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, Guangxi Normal University, Guilin, 541004, China.
| |
Collapse
|
2
|
Evren AE, Karaduman AB, Sağlik BN, Özkay Y, Yurttaş L. Investigation of Novel Quinoline-Thiazole Derivatives as Antimicrobial Agents: In Vitro and In Silico Approaches. ACS OMEGA 2023; 8:1410-1429. [PMID: 36643421 PMCID: PMC9835529 DOI: 10.1021/acsomega.2c06871] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Accepted: 12/19/2022] [Indexed: 06/17/2023]
Abstract
Infectious diseases are a major concern around the world. Today, it is an urgent need for new chemotherapeutics for infectious diseases. Because of that, our group designed, synthesized, and analyzed 14 new quinoline derivatives endowed with the pharmacophore moiety of fluoroquinolones primarily for their antimicrobial effects. Their cytotoxicity effects were tested against six bacterial and four fungal strains and NIH/3T3 cell line. Additionally, their action mechanisms were evaluated against DNA gyrase and lanosterol 14α-demethylase (LMD). Furthermore, to eliminate the potential side effects, the active compounds were evaluated against the aromatase enzyme. The experimental enzymatic results were evaluated for active compounds' binding modes using molecular docking and molecular dynamics simulation studies. The results were utilized to clarify the structure-activity relationship (SAR). Finally, compound 4m was the most potent compound for its antifungal activity with low cytotoxicity against healthy cells and fewer possible side effects, while compounds 4j and 4l can be used alone for special patients who are suffering from fungal infections in addition to the primer disease.
Collapse
Affiliation(s)
- Asaf Evrim Evren
- Department
of Pharmacy Services, Vocational School of Health Services, Bilecik Şeyh Edebali University, Bilecik 11000, Turkey
- Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey
| | - Abdullah Burak Karaduman
- Department
of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey
| | - Begüm Nurpelin Sağlik
- Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey
- Central
Research Laboratory, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey
| | - Yusuf Özkay
- Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey
- Central
Research Laboratory, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey
| | - Leyla Yurttaş
- Department
of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskişehir 26470, Turkey
| |
Collapse
|
3
|
Studies on the antibacterial activities and molecular mechanism of GyrB inhibitors by 3D-QSAR, molecular docking and molecular dynamics simulation. ARAB J CHEM 2022. [DOI: 10.1016/j.arabjc.2022.103872] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
4
|
de Araújo-Neto JB, da Silva MMC, Oliveira-Tintino CDDM, Begnini IM, Rebelo RA, da Silva LE, Mireski SL, Nasato MC, Krautler MIL, Ribeiro-Filho J, Siyadatpanah A, Wilairatana P, Coutinho HDM, Tintino SR. Enhancement of Antibiotic Activity by 1,8-Naphthyridine Derivatives against Multi-Resistant Bacterial Strains. Molecules 2021; 26:7400. [PMID: 34885981 PMCID: PMC8659213 DOI: 10.3390/molecules26237400] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2021] [Revised: 12/02/2021] [Accepted: 12/04/2021] [Indexed: 11/24/2022] Open
Abstract
The search for new antibacterial agents has become urgent due to the exponential growth of bacterial resistance to antibiotics. Nitrogen-containing heterocycles such as 1,8-naphthyridine derivatives have been shown to have excellent antimicrobial properties. Therefore, the purpose of this study was to evaluate the antibacterial and antibiotic-modulating activities of 1,8-naphthyridine derivatives against multi-resistant bacterial strains. The broth microdilution method was used to determine the minimum inhibitory concentration (MIC) of the following compounds: 7-acetamido-1,8-naphthyridin-4(1H)-one and 3-trifluoromethyl-N-(5-chloro-1,8-naphthyridin-2-yl)-benzenesulfonamide. The antibiotic-modulating activity was analyzed using subinhibitory concentrations (MIC/8) of these compounds in combination with norfloxacin, ofloxacin, and lomefloxacin. Multi-resistant strains of Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus were used in both tests. Although the compounds had no direct antibacterial activity (MIC ≥ 1.024 µg/mL), they could decrease the MIC of these fluoroquinolones, indicating synergism was obtained from the association of the compounds. These results suggest the existence of a structure-activity relationship in this group of compounds with regard to the modulation of antibiotic activity. Therefore, we conclude that 1,8-naphthyridine derivatives potentiate the activity of fluoroquinolone antibiotics against multi-resistant bacterial strains, and thereby interesting candidates for the development of drugs against bacterial infections caused by multidrug resistant strains.
Collapse
Affiliation(s)
- José B. de Araújo-Neto
- Laboratory of Microbiology and Molecular Biology (LMBM), Regional University of Cariri—URCA, Crato 63105-000, CE, Brazil; (J.B.d.A.-N.); (M.M.C.d.S.); (C.D.d.M.O.-T.); (S.R.T.)
| | - Maria M. C. da Silva
- Laboratory of Microbiology and Molecular Biology (LMBM), Regional University of Cariri—URCA, Crato 63105-000, CE, Brazil; (J.B.d.A.-N.); (M.M.C.d.S.); (C.D.d.M.O.-T.); (S.R.T.)
| | - Cícera D. de M. Oliveira-Tintino
- Laboratory of Microbiology and Molecular Biology (LMBM), Regional University of Cariri—URCA, Crato 63105-000, CE, Brazil; (J.B.d.A.-N.); (M.M.C.d.S.); (C.D.d.M.O.-T.); (S.R.T.)
| | - Iêda M. Begnini
- Department of Chemistry, Regional University of Blumenau—FURB, Itoupava Seca, Blumenau 89012-900, SC, Brazil; (I.M.B.); (R.A.R.); (S.L.M.); (M.C.N.); (M.I.L.K.)
| | - Ricardo A. Rebelo
- Department of Chemistry, Regional University of Blumenau—FURB, Itoupava Seca, Blumenau 89012-900, SC, Brazil; (I.M.B.); (R.A.R.); (S.L.M.); (M.C.N.); (M.I.L.K.)
| | - Luiz E. da Silva
- Postgraduate Program in Sustainable Territorial Development—Coastal Sector, Federal University of Paraná, Curitiba 80060-000, PR, Brazil;
| | - Sandro L. Mireski
- Department of Chemistry, Regional University of Blumenau—FURB, Itoupava Seca, Blumenau 89012-900, SC, Brazil; (I.M.B.); (R.A.R.); (S.L.M.); (M.C.N.); (M.I.L.K.)
| | - Michele C. Nasato
- Department of Chemistry, Regional University of Blumenau—FURB, Itoupava Seca, Blumenau 89012-900, SC, Brazil; (I.M.B.); (R.A.R.); (S.L.M.); (M.C.N.); (M.I.L.K.)
| | - Maria I. L. Krautler
- Department of Chemistry, Regional University of Blumenau—FURB, Itoupava Seca, Blumenau 89012-900, SC, Brazil; (I.M.B.); (R.A.R.); (S.L.M.); (M.C.N.); (M.I.L.K.)
| | - Jaime Ribeiro-Filho
- Gonçalo Moniz Institute, Oswaldo Cruz Foundation (IGM-FIOCRUZ/BA), Rua Waldemar Falcão, 121, Candeal, Salvador 40296-710, BA, Brazil;
| | - Abolghasem Siyadatpanah
- Ferdows School of Paramedical and Health, Birjand University of Medical Sciences, Birjand 9717853577, Iran
- Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand 9717853577, Iran
| | - Polrat Wilairatana
- Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand
| | - Henrique D. M. Coutinho
- Laboratory of Microbiology and Molecular Biology (LMBM), Regional University of Cariri—URCA, Crato 63105-000, CE, Brazil; (J.B.d.A.-N.); (M.M.C.d.S.); (C.D.d.M.O.-T.); (S.R.T.)
| | - Saulo R. Tintino
- Laboratory of Microbiology and Molecular Biology (LMBM), Regional University of Cariri—URCA, Crato 63105-000, CE, Brazil; (J.B.d.A.-N.); (M.M.C.d.S.); (C.D.d.M.O.-T.); (S.R.T.)
| |
Collapse
|
5
|
Ojha M, Yadav D, Kumar A, Dasgupta S, Yadav R. 1,8-Naphthyridine Derivatives: A Privileged Scaffold for Versatile Biological Activities. Mini Rev Med Chem 2021; 21:586-601. [PMID: 33038911 DOI: 10.2174/1389557520666201009162804] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2020] [Revised: 06/27/2020] [Accepted: 08/10/2020] [Indexed: 11/22/2022]
Abstract
1, 8- Naphthyridine nucleus belongs to significant nitrogen-containing heterocyclic compounds which has garnered the interest of researchers due to its versatile biological activities. It is known to be used as an antimicrobial, anti-psychotic, anti-depressant, anti-convulsant, anti- Alzheimer's, anti-cancer, analgesic, anti-inflammatory, antioxidant, anti-viral, anti-hypertensive, antimalarial, pesticides, anti-platelets, and CB2 receptor agonist, etc. The present review highlights the framework of biological properties of synthesized 1, 8-naphthyridine derivatives developed by various research groups across the globe.
Collapse
Affiliation(s)
- Madhwi Ojha
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan-304022, India
| | - Divya Yadav
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan-304022, India
| | - Avinash Kumar
- Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, Karnataka- 576104, India
| | - Suman Dasgupta
- Department of Molecular Biology & Biotechnology, Tezpur University, Nappam, Sonitpur-784028, Assam, India
| | - Rakesh Yadav
- Department of Pharmacy, Banasthali Vidyapith, Banasthali, Rajasthan-304022, India
| |
Collapse
|
6
|
1,8-naphthyridine derivatives: an updated review on recent advancements of their myriad biological activities. Future Med Chem 2021; 13:1591-1618. [PMID: 34256591 DOI: 10.4155/fmc-2021-0086] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023] Open
Abstract
Among all nitrogen-containing heterocycles, the 1,8-naphthyridine scaffold has recently gained an immense amount of curiosity from numerous researchers across fields of medicinal chemistry and drug discovery. This new attention can be ascribed to its versatility of synthesis, its reactiveness and the variety of biological activities it has exhibited. Over the past half-decade, numerous diverse biological evaluations have been conducted on 1,8-naphthyridine and its derivatives in a quest to unravel novel pharmacological facets to this scaffold. Its potency to treat neurodegenerative and immunomodulatory disorders, along with its anti-HIV, antidepressant and antioxidant properties, has enticed researchers to look beyond its broad-spectrum activities, providing further scope for exploration. This review is a consolidated update of previous works on 1,8-naphthyridines and their analogs, focusing on the past 5 years.
Collapse
|
7
|
Jaswal S, Nehra B, Kumar S, Monga V. Recent advancements in the medicinal chemistry of bacterial type II topoisomerase inhibitors. Bioorg Chem 2020; 104:104266. [PMID: 33142421 DOI: 10.1016/j.bioorg.2020.104266] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Revised: 08/14/2020] [Accepted: 08/31/2020] [Indexed: 02/06/2023]
Abstract
Replication proteins are sought as a potential targets for antimicrobial agents. Despite their promising target characteristics, only topoisomerase II inhibitors targeting DNA gyrase and/or topoisomerase IV have reached clinical use. Topoisomerases are the enzymes that are essential for cellular functions and various biological activities. A wide range of natural and synthetic compounds have been identified as potential topoisomerase inhibitors but the resistance is most commonly found in these drugs. The emergence of FQ resistance has increased the need for the development of novel topoisomerase inhibitors with efficacy and high potency against FQ-resistant strains. Besides structural modifications of existing FQ scaffolds, novel non-quinolone topoisomerase II inhibitors, known as novel bacterial topoisomerase inhibitors, have been developed which showed remarkable inhibitory activity against DNA gyrase/topoisomerase IV or both with an improved spectrum of antibacterial potency including drug-resistant strains. This review aims to summarize various recent advancements in the medicinal chemistry of topoisomerase inhibitors with the following objectives: (1) To represent inclusive data on types of topoisomerases and various marketed topoisomerase inhibitors as drugs; (2) To discuss the recent advances in the medicinal chemistry of various topoisomerase inhibitors (DNA gyrase and topo IV) belonging to different structural classes as potential antibacterial agents; (3) To summarizes the structure activity relationship (SAR) including in silico and mechanistic studies to afford ideas and to provide focused direction for the development of new chemical entities which are effective against drug-resistant bacterial pathogens and biofilms.
Collapse
Affiliation(s)
- Shalini Jaswal
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, GT Road, Ghal Kalan, Moga 142001, Punjab, India
| | - Bhupender Nehra
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, GT Road, Ghal Kalan, Moga 142001, Punjab, India
| | - Shubham Kumar
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, GT Road, Ghal Kalan, Moga 142001, Punjab, India
| | - Vikramdeep Monga
- Department of Pharmaceutical Chemistry, ISF College of Pharmacy, GT Road, Ghal Kalan, Moga 142001, Punjab, India.
| |
Collapse
|
8
|
Recent advances in DNA gyrase-targeted antimicrobial agents. Eur J Med Chem 2020; 199:112326. [DOI: 10.1016/j.ejmech.2020.112326] [Citation(s) in RCA: 31] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2019] [Revised: 04/07/2020] [Accepted: 04/08/2020] [Indexed: 12/16/2022]
|
9
|
Salem MA, Ragab A, Askar AA, El-Khalafawy A, Makhlouf AH. One-pot synthesis and molecular docking of some new spiropyranindol-2-one derivatives as immunomodulatory agents and in vitro antimicrobial potential with DNA gyrase inhibitor. Eur J Med Chem 2020; 188:111977. [DOI: 10.1016/j.ejmech.2019.111977] [Citation(s) in RCA: 48] [Impact Index Per Article: 12.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2019] [Revised: 11/07/2019] [Accepted: 12/16/2019] [Indexed: 12/17/2022]
|
10
|
Seliem IA, Panda SS, Girgis AS, Nagy YI, George RF, Fayad W, Fawzy NG, Ibrahim TS, Al‐Mahmoudy AMM, Sakhuja R, Abdel‐samii ZKM. Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone–dichloroacetic acid hybrids. Chem Biol Drug Des 2019; 95:248-259. [DOI: 10.1111/cbdd.13638] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2019] [Revised: 08/30/2019] [Accepted: 10/12/2019] [Indexed: 11/28/2022]
Affiliation(s)
- Israa A. Seliem
- Department of Chemistry and Physics Augusta University Augusta GA USA
- Department of Pharmaceutical Organic Chemistry Faculty of Pharmacy Zagazig University Zagazig Egypt
| | - Siva S. Panda
- Department of Chemistry and Physics Augusta University Augusta GA USA
| | - Adel S. Girgis
- Department of Pesticide Chemistry National Research Centre Giza Egypt
| | - Yosra I. Nagy
- Microbiology and Immunology Department Faculty of Pharmacy Cairo University Cairo Egypt
| | - Riham F. George
- Pharmaceutical Chemistry Department Faculty of Pharmacy Cairo University Cairo Egypt
| | - Walid Fayad
- Drug Bioassay‐Cell Culture Laboratory Pharmacognosy Department National Research Centre Giza Egypt
| | - Nehmedo G. Fawzy
- Department of Pesticide Chemistry National Research Centre Giza Egypt
| | - Tarek S. Ibrahim
- Department of Pharmaceutical Organic Chemistry Faculty of Pharmacy Zagazig University Zagazig Egypt
- Department of Pharmaceutical Chemistry Faculty of Pharmacy King Abdulaziz University Jeddah Saudi Arabia
| | - Amany M. M. Al‐Mahmoudy
- Department of Pharmaceutical Organic Chemistry Faculty of Pharmacy Zagazig University Zagazig Egypt
| | - Rajeev Sakhuja
- Department of Chemistry Birla Institute of Technology and Science Pilani India
| | | |
Collapse
|
11
|
Design, synthesis and molecular modeling studies on novel moxifloxacin derivatives as potential antibacterial and antituberculosis agents. Bioorg Chem 2019; 88:102965. [DOI: 10.1016/j.bioorg.2019.102965] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2018] [Revised: 04/27/2019] [Accepted: 04/29/2019] [Indexed: 12/30/2022]
|
12
|
Hou X, Luo H, Zhang M, Yan G, Pu C, Lan S, Li R. Synthesis and biological evaluation of 3-(1,3,4-oxadiazol-2-yl)-1,8-naphthyridin-4(1 H)-ones as cisplatin sensitizers. MEDCHEMCOMM 2018; 9:1949-1960. [PMID: 30568762 PMCID: PMC6256366 DOI: 10.1039/c8md00464a] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/14/2018] [Accepted: 09/22/2018] [Indexed: 02/05/2023]
Abstract
A series of novel 3-(1,3,4-oxadiazol-2-yl)-1,8-naphthyridin-4(1H)-one derivatives were synthesized and their anti-cancer as well as cisplatin sensitization activities were evaluated. Among them, compounds 6e and 6h exhibited significant cisplatin sensitization activity against HCT116. Hoechst staining and annexin V-FITC/PI dual-labeling studies demonstrated that the combination of 6e/6h and cisplatin can induce tumour cell apoptosis. Western blot showed that the expression of ATR downstream protein, CHK1, decreased in 6e + cisplatin and 6h + cisplatin groups compared with that in the test compound and cisplatin group. Furthermore, docking of 6e/6h into the ATR structure active site revealed that the N1 and N8 atoms in the naphthyridine ring and the hybrid atom in the oxadiazole ring are involved in hydrogen bonding with Val170, Glu168 and Tyr155. Additionally, the naphthyridine ring is also involved in π-π stacking with Trp169. Accordingly, compounds 6e and 6h can be expected to be potential cisplatin sensitizers that can participate in HCT116 cancer therapy.
Collapse
Affiliation(s)
- Xueyan Hou
- State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy , West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , P. R. China .
- College of Pharmacy , Xinxiang Medical University , Xinxiang , Henan 453003 , P.R. China
| | - Hao Luo
- State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy , West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , P. R. China .
| | - Mengqi Zhang
- State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy , West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , P. R. China .
| | - Guoyi Yan
- State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy , West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , P. R. China .
| | - Chunlan Pu
- State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy , West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , P. R. China .
| | - Suke Lan
- State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy , West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , P. R. China .
| | - Rui Li
- State Key Laboratory of Biotherapy/Collaborative Innovation Center of Biotherapy , West China Hospital , Sichuan University , Chengdu , Sichuan 610041 , P. R. China .
| |
Collapse
|
13
|
Karaman N, Adil Zainel R, Kapkaç HA, Karaca Gençer H, Ilgın S, Karaduman AB, Karaküçük-İyidoğan A, Oruç-Emre EE, Koçyiğit-Kaymakçıoğlu B. Design and evaluation of biological activities of 1,3-oxazolidinone derivatives bearing amide, sulfonamide, and thiourea moieties. Arch Pharm (Weinheim) 2018; 351:e1800057. [DOI: 10.1002/ardp.201800057] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2018] [Revised: 07/06/2018] [Accepted: 07/11/2018] [Indexed: 12/19/2022]
Affiliation(s)
- Nurcan Karaman
- Faculty of Arts and Sciences, Department of Chemistry; Gaziantep University; Gaziantep Turkey
| | - Rabeah Adil Zainel
- Faculty of Arts and Sciences, Department of Chemistry; Gaziantep University; Gaziantep Turkey
| | - Handan A. Kapkaç
- Faculty of Science, Department of Biology; Anadolu University; Eskisehir Turkey
| | - Hülya Karaca Gençer
- Faculty of Pharmacy, Department of Pharmaceutical Microbiology; Anadolu University; Eskisehir Turkey
| | - Sinem Ilgın
- Faculty of Pharmacy, Department of Pharmaceutical Toxicology; Anadolu University; Eskisehir Turkey
| | - A. Burak Karaduman
- Faculty of Pharmacy, Department of Pharmaceutical Toxicology; Anadolu University; Eskisehir Turkey
| | | | - Emine E. Oruç-Emre
- Faculty of Arts and Sciences, Department of Chemistry; Gaziantep University; Gaziantep Turkey
| | | |
Collapse
|
14
|
Jiang D. 4-Quinolone Derivatives and Their Activities Against Gram-negative Pathogens. J Heterocycl Chem 2018. [DOI: 10.1002/jhet.3244] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Dan Jiang
- School of Nuclear Technology and Chemistry & Biology; Hubei University of Science and Technology; Xianning Hubei China
| |
Collapse
|
15
|
Khan T, Sankhe K, Suvarna V, Sherje A, Patel K, Dravyakar B. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomed Pharmacother 2018; 103:923-938. [DOI: 10.1016/j.biopha.2018.04.021] [Citation(s) in RCA: 63] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/02/2018] [Revised: 03/24/2018] [Accepted: 04/03/2018] [Indexed: 12/22/2022] Open
|
16
|
Ilgın S, Osmaniye D, Levent S, Sağlık BN, Acar Çevik U, Çavuşoğlu BK, Özkay Y, Kaplancıklı ZA. Design and Synthesis of New Benzothiazole Compounds as Selective hMAO-B Inhibitors. Molecules 2017; 22:E2187. [PMID: 29232838 PMCID: PMC6149824 DOI: 10.3390/molecules22122187] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2017] [Revised: 12/01/2017] [Accepted: 12/08/2017] [Indexed: 11/16/2022] Open
Abstract
In the current work a new class of novel benzothiazole-hydrazone derivatives was designed and synthesized as hMAO-B inhibitors. Structures of the obtained compounds (3a-3j) were characterized by IR, ¹H-NMR, 13C-NMR, and HRMS spectroscopic methods. The inhibitory activity of compounds (3a-3j) against hMAO-A and hMAO-B enzymes was evaluated by using an in vitro fluorometric method. According to activity results, some of the synthesized compounds displayed selective and significant hMAO-B enzyme inhibitor activity. Compound 3e was the most active derivative in the series with an IC50 value of 0.060 µM. Furthermore, cytotoxicity of compound 3e was investigated and found to be non-cytotoxic. Absorption, distribution, metabolism, and excretion (ADME) and blood-brain barrier (BBB) permeability predictions were performed for all compounds. It was determined that these compounds may have a good pharmacokinetic profiles. Bınding modes between the most active compound 3e and the hMAO-B enzyme were analyzed by docking studies. It was observed that there is a strong interaction between compound 3e and enzyme active site.
Collapse
Affiliation(s)
- Sinem Ilgın
- Department of Pharmaceutical Toxicology, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| | - Derya Osmaniye
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
- Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| | - Serkan Levent
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
- Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| | - Begüm Nurpelin Sağlık
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
- Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| | - Ulviye Acar Çevik
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
- Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| | - Betül Kaya Çavuşoğlu
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| | - Yusuf Özkay
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
- Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| | - Zafer Asım Kaplancıklı
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu Universty, 26470, Eskişehir, Turkey.
| |
Collapse
|
17
|
4-Quinolone hybrids and their antibacterial activities. Eur J Med Chem 2017; 141:335-345. [DOI: 10.1016/j.ejmech.2017.09.050] [Citation(s) in RCA: 134] [Impact Index Per Article: 19.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2017] [Revised: 09/11/2017] [Accepted: 09/24/2017] [Indexed: 01/28/2023]
|
18
|
Khalifa NM, Al-Omar MA, Ahmed NS. Synthesis and reactions of some novel 1-(2,7-dimethyl-1,8-naphthyridin-4-yl)hydrazine candidates. RUSS J GEN CHEM+ 2017. [DOI: 10.1134/s1070363217100292] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
19
|
Khalifa NM, Al-Omar MA, Ali OM. Synthesis and reactions of some new (E)-2-сyano-N′-[1-(pyren-3-yl)ethylidene]acetohydrazide derivatives. RUSS J GEN CHEM+ 2017. [DOI: 10.1134/s1070363217090250] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
20
|
Başaran E. Ocular Application of Dirithromycin Incorporated Polymeric Nanoparticles: an In Vitro Evaluation. Turk J Pharm Sci 2017; 14:191-200. [PMID: 32454613 DOI: 10.4274/tjps.69855] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2017] [Accepted: 04/27/2017] [Indexed: 01/06/2023]
Abstract
Objectives Ocular drug delivery is a difficult challenge especially with topical intillation which results in rapid drainage and non-productive drug absorption. For the improvement of the pre-corneal retention time and enhancing the corneal permeability, colloidal drug delivery systems play an important role in enhancement of the ocular bioavailability. In this study, dirithromycin incorporated Kollidon® SR-based polymeric nanoparticles, an antibacterial agent, were formulated for the efficient treatment of severe ocular bacterial infections. Materials and Methods In this study, dirithromycin was incorporated into the Kollidon® SR-based nanoparticles by spray drying method. In vitro characteristic properties were evaluated in detail during the storage period of three months at three different conditions. Results The results of in vitro analyses revealed that characteristic properties of the particles were remained unchanged during the storage period of three months. Conclusion Kollidon® SR-based polymeric nanoparticles are good candidates for drug delivery systems in the treatment of severe ocular bacterial infections with dirithromycin.
Collapse
Affiliation(s)
- Ebru Başaran
- Anadolu University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Eskişehir, Turkey
| |
Collapse
|